Diligent Pharma
PrivateLast Round
Series A
May 15, 2023
Total Funding Raised
$8.27M
Company Overview
Diligent Pharma is a pharmaceuticals and biotechnology company that provides a cloud-based research platform designed to streamline the selection and qualification of clinical trial service providers.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Compliance & Risk, Vertical SaaS, Quality Management
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Diligent Pharma Comparables
Compare Diligent Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Strategikon Pharma | 76% | |
| ClinAI | 74% | |
| Veeva Systems | 72% |
Diligent Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 15, 2023 |
Key People
Founding team and executive leadership
Diligent Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GenHenn Capital | Series A |
| PJC | Series A |
| FCA Venture Partners | Series A |
Diligent Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Diligent Pharma's valuation, stock price, and market status.
Is Diligent Pharma a public or private company?
Diligent Pharma is a private company.
What is the current stock price of Diligent Pharma?
Diligent Pharma is a private company with no public stock price. No recent secondary market data is available.
How much is Diligent Pharma worth (valuation)?
Valuation information for Diligent Pharma is not publicly available.
Can I buy Diligent Pharma stock?
Diligent Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Diligent Pharma's last funding round?
Diligent Pharma's most recent funding round was Series A on May 15, 2023.
Who are the main investors in Diligent Pharma?
Key investors in Diligent Pharma include FCA Venture Partners.
Will Diligent Pharma IPO soon?
No public IPO plans have been announced for Diligent Pharma.
How can I track Diligent Pharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Diligent Pharma's secondary market activity and sign up for updates.